Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Diphenhydramine × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Leukemia, Hairy Cell 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vomiting 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Postoperative Nausea and Vomiting 1 Philadelphia Chromosome 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Papillomavirus Infections 1 Oropharyngeal Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 NSCLC 1 Myelodysplastic Syndromes 1 Lymphoma, Follicular 1 Lymphoma, B-Cell 1 Leukemia, B-Cell 1

Interventions

Nivolumab 63 pembrolizumab 62 cabozantinib 43 Ipilimumab 33 Magnetic Resonance Spectroscopy 30 Specimen Handling 26 lenvatinib 21 Axitinib 20 belzutifan 16 Sunitinib 16 Radiosurgery 13 Biopsy 13 atezolizumab 10 Everolimus 10 CTLA-4 Antigen 10 pazopanib 9 avelumab 8 Radiotherapy 8 Bevacizumab 8 fludarabine 6 cemiplimab 6 aldesleukin 6 Standard of Care 6 Nephrectomy 6 Immunoglobulin G 6 Cyclophosphamide 6 toripalimab 5 spartalizumab 5 Paclitaxel 5 tivozanib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡